ArticleMolecular therapy oncolytics2019

GBM-Targeted oHSV Armed with Matrix Metalloproteinase 9 Enhances Anti-tumor Activity and Animal Survival.

Paola Sette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.